Intrexon





Ebit Veränderung Datum
Agenus USD -13.31M 19.08M 2025-03
Alaunos Therapeutics USD -1.19M 148K 2025-09
Amgen USD 3.96B 464M 2025-12
Anika Therapeutics USD -4.28M 3.58M 2025-03
Arrowhead Research USD 40.81M 17.01M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Heron Therapeutics USD -4.46M 5.76M 2024-09
Incyte USD 383.88M 47.44M 2025-12
Intrexon USD -26.3M 2.91M 2024-06
Karyopharm Therapeutics USD -26.28M 1.84M 2024-09
Ligand Pharmaceuticals USD 158.89M 115.32M 2025-09
MacroGenics USD 20.16M 55.51M 2025-09
MannKind USD -41.05M 2.36M 2025-09
Merck USD 6.24B 1.32B 2025-12
Novartis USD -9.19B 13.87B 2025-06
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Roche Holding CHF 9.56B 2.1B 2025-12
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Veracyte USD 23.11M 8.8M 2025-09
Xencor USD -47.52M 24.69M 2025-09


Intrexon - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.